SK Biopharmaceuticals is a pharmaceutical company based in South Korea that researches and develops medicines for disorders of the central nervous system. Its main product is an epilepsy treatment that it develops and supplies to patients and healthcare providers in markets including the United States and Europe. The company also works on other neurological and oncology candidates through its own research and partnerships, and it earns revenue from product sales and licensing arrangements with pharmaceutical partners.
The shares are listed on the Korea Stock Exchange in Korea under the code 326030, and the price on this page is in South Korean won (KRW). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #578 of 934 on the Korea Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Korea yet.
TrendWeak
27/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-20.3%
From 52-week high-45.8%
MomentumWeak
39/100
Lagging most stocks on this exchange.
See the numbers →
3-month return2.1%
6-month return-22.6%
12-month, skipping last month-22.0%
Stability (higher is calmer)Weak
46/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)46.5%
Worst drawdown, 1 year (smaller is calmer)-50.7%
LiquidityStrong
82/100
Trades actively.
See the numbers →
Avg daily value traded10,410.85M KRW
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Korea when fundamentals data for this market is added. All Korea stocks.
52-wk range 67,800.00 – 144,100.00Daily closes, split-adjusted
Signals
50-day average81,188.00
200-day average95,666.50
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2,922.33
Technical summary
Daily
Bearish
5 bullish · 2 neutral · 9 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
73,200.0
Bullish
EMA 10
73,471.5
Bullish
SMA 20
74,985.0
Bullish
EMA 20
75,236.1
Bullish
SMA 50
81,188.0
Bearish
EMA 50
79,179.9
Bearish
SMA 100
83,162.0
Bearish
EMA 100
84,102.4
Bearish
SMA 200
95,666.5
Bearish
EMA 200
91,283.6
Bearish
Oscillators (daily)
RSI (14)
49.51
Neutral
MACD (12, 26)
-2,455.4
Bearish
Momentum (12)
1.74
Bullish
Stochastic %K (14)
82.35
Bearish
Williams %R (14)
-17.65
Bearish
CCI (20)
-0.82
Neutral
Pivot points (classic, last session)
S3
69,600.0
S2
71,000.0
S1
73,600.0
Pivot
75,000.0
R1
77,600.0
R2
79,000.0
R3
81,600.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in KRW. Educational only, not financial advice.
